Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Al Mayadeen's correspondent: Two were martyred in an initial toll of the Israeli drone strike that targeted the al-Asira neighborhood in the city of Baalbek, eastern Lebanon
Al Mayadeen's correspondent: An Israeli drone strike targeted the al-Asira neighborhood east of Baalbek, eastern Lebanon
Sheikh Naim Qassem to the pager attack survivors: You are the greatest resistance. Know that 'Israel' will fall because it embodies aggression, crime, and occupation; victory is truly yours
Sheikh Qassem to the pager attack survivors: The value of what you are doing despite your wounds is immense, and here you are, treading the path of the Master of Nation's Martyrs and the leaders
Sheikh Qassem to the pager attack survivors: You are moving forward with insight deeper than sight itself. The enemy sought to eliminate your role in the battle, yet you remain steadfast and continue the fight
Hezbollah Secretary-General Sheikh Naim Qassem to the pager attack survivors one year later: You are healing from your wounds and rising above them. You have successfully passed the test
Palestinian media: Reports of stabbing operation in occupied al-Quds.
Israeli media: Sirens blare in Arava in South, near Ramon Airport.
Egyptian PM Mostafa Madbouli: Egypt is targeted in plans to redraw regional map
AEOI Chief Mohammad Eslami: Our presence in IAEA General Council and fact-checking helped in preventing unilateral rhetoric that aims to portray Iran as an unregulated country

Hopes for cancer cure as personal mRNA vaccine for melanoma trialled

  • By Al Mayadeen English
  • Source: News Websites
  • 26 Apr 2024 16:53
  • 1 Shares
3 Min Read

Experts are currently studying new jabs that are custom-built for each patient and instruct their bodies to hunt out cancer cells to prevent the return of the disease.

  • x
  • Hopes for cancer cure as personal mRNA vaccine for melanoma trialled
    A nurse administers the third dose of an experimental breast cancer vaccine to patient Kathleen Jade at the University of Washington Medical Center in Seattle on May 30, 2023 (AP)

Physicians have begun testing the world's first personalized mRNA cancer vaccine for melanoma on a number of patients, with experts hailing its "game-changing" ability to irreversibly cure cancer. 

Melanoma affects around 132,000 individuals worldwide each year and is the leading cause of death from skin cancer. Currently, surgery is the primary treatment, however radiation, medications, and chemotherapy are occasionally employed.

Experts are currently studying new jabs that are custom-built for each patient and instruct their bodies to hunt out cancer cells to prevent the return of the disease.

A phase 2 experiment indicated that the immunizations significantly lowered the probability of cancer recurrence in melanoma patients. A final phase 3 experiment has been initiated, conducted by University College London Hospitals NHS Foundation Trust (UCLH).

MRNA therapy was administered to the first UK patients in February to evaluate the therapy’s safety and effectiveness in treating melanoma, lung cancer, and other solid tumors.

Dr. Heather Shaw, the trial's national coordinating investigator, indicated that the shots have the potential to cure melanoma and are being studied for other malignancies such as lung, bladder, and kidney.

Read more: Dr. Philip Salem: Lebanese architect of the cancer cure, ICTriplex

Shaw called the technology a “really finely honed tool," adding that the patients are "really excited about them."

Related News

Russia completes preclinical trials of cancer vaccine, seeks approval

Biden diagnosed with 'aggressive' prostate cancer

The vaccination is an individualized neoantigen treatment. It is meant to activate the immune system so that it can fight back against a patient's particular kind.

The mRNA-4157 (V940) vaccine, targets cancer neoantigens that are expressed by tumors in a specific patient. These are tumor-specific signals that the immune system may identify.

The jab contains code for up to 34 neoantigens and stimulates an anti-tumor immune response based on the specific mutations found in a patient's malignancy.

To personalize it, a tumor sample is extracted during the patient's operation, which is then sequenced using DNA and artificial intelligence. As a consequence, the patient receives a personalized anti-cancer vaccine tailored to his or her tumor.

“It is absolutely custom-built for the patient," Shaw cited. “They may have some shared new antigens, but they’re likely to have their own very individual new antigens that are important to their tumour and so, therefore, it is truly personalized.”

Shaw stated that the ultimate goal is to permanently cure people of cancer

According to Phase 2 data, persons with significant high-risk melanomas who received the jab alongside the immunotherapy Keytruda were nearly half (49%) as likely to die or have their disease return after three years as those who had only Keytruda.

Patients received 1mg of the mRNA vaccine every three weeks for a maximum of nine doses, followed by 200mg of Keytruda every three weeks (maximum of 18 doses) for approximately a year.

The phase 3 worldwide study will now encompass a broader variety of patients and seeks to enroll around 1,100 participants. The UK arm plans to enroll at least 60 to 70 patients across eight centers, including London, Manchester, Edinburgh, and Leeds.

Steve Young, 52, of Stevenage, Hertfordshire, is one of the first patients to participate in the UCLH experiment. "I'm really, really excited," he remarked. "This is my best chance at stopping the cancer in its tracks."

  • Cancer
  • Cancer patients
  • cancer treatment
  • cancer research
  • mRNA
  • melanoma

Most Read

Pro-"Israel" conservative Charlie Kirk shot during Utah speech

American far-right activist Charlie Kirk shot dead during Utah speech

  • US & Canada
  • 11 Sep 2025
Uprising against Volker Turk at the Human Rights Council over Gaza.

Uprising against Volker Turk at the Human Rights Council over Gaza

  • Politics
  • 12 Sep 2025
A screengrab from the ad played on Fox News. (X Screengrab)

Fox airs ad warning Trump not to let Netanyahu 'play' him on Gaza

  • US & Canada
  • 11 Sep 2025
Lapid: Egypt’s Arab Force plan a 'severe blow' to normalization

Lapid: Egypt’s Arab Force plan a 'severe blow' to normalization

  • Palestine
  • 14 Sep 2025

Coverage

All
The Ummah's Martyrs

Read Next

All
Britain Trained Israeli Soldiers Involved in Gaza War: Declassified
Europe

UK training of Israeli officers sparks outcry over Gaza war complicity

Luxembourg's Prime Minister Luc Frieden arrives for an EU summit at the European Council building in Brussels, Thursday, June 26, 2025. (AP Photo/Omar Havana)
Politics

Luxembourg to recognize Palestine at UN summit next week

European Union flags flap in the wind outside EU headquarters in Brussels, Wednesday, Sept. 3, 2025 (AP)
Politics

EU exec. branch to adopt new sanctions against 'Israel' on Wednesday

Charlie Kirk killing suspect faces charges in Utah court hearing
US & Canada

Charlie Kirk murder suspect faces formal charges in Utah court hearing

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS